K2P18.1 translates T cell receptor signals into thymic regulatory T cell development
© 2021. The Author(s)..
It remains largely unclear how thymocytes translate relative differences in T cell receptor (TCR) signal strength into distinct developmental programs that drive the cell fate decisions towards conventional (Tconv) or regulatory T cells (Treg). Following TCR activation, intracellular calcium (Ca2+) is the most important second messenger, for which the potassium channel K2P18.1 is a relevant regulator. Here, we identify K2P18.1 as a central translator of the TCR signal into the thymus-derived Treg (tTreg) selection process. TCR signal was coupled to NF-κB-mediated K2P18.1 upregulation in tTreg progenitors. K2P18.1 provided the driving force for sustained Ca2+ influx that facilitated NF-κB- and NFAT-dependent expression of FoxP3, the master transcription factor for Treg development and function. Loss of K2P18.1 ion-current function induced a mild lymphoproliferative phenotype in mice, with reduced Treg numbers that led to aggravated experimental autoimmune encephalomyelitis, while a gain-of-function mutation in K2P18.1 resulted in increased Treg numbers in mice. Our findings in human thymus, recent thymic emigrants and multiple sclerosis patients with a dominant-negative missense K2P18.1 variant that is associated with poor clinical outcomes indicate that K2P18.1 also plays a role in human Treg development. Pharmacological modulation of K2P18.1 specifically modulated Treg numbers in vitro and in vivo. Finally, we identified nitroxoline as a K2P18.1 activator that led to rapid and reversible Treg increase in patients with urinary tract infections. Conclusively, our findings reveal how K2P18.1 translates TCR signals into thymic T cell fate decisions and Treg development, and provide a basis for the therapeutic utilization of Treg in several human disorders.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Cell research - 32(2022), 1 vom: 26. Jan., Seite 72-88 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ruck, Tobias [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Forkhead Transcription Factors |
|---|
| Anmerkungen: |
Date Completed 27.01.2022 Date Revised 07.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41422-021-00580-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332413454 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332413454 | ||
| 003 | DE-627 | ||
| 005 | 20231225215529.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41422-021-00580-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1108.xml |
| 035 | |a (DE-627)NLM332413454 | ||
| 035 | |a (NLM)34702947 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ruck, Tobias |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a K2P18.1 translates T cell receptor signals into thymic regulatory T cell development |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.01.2022 | ||
| 500 | |a Date Revised 07.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a It remains largely unclear how thymocytes translate relative differences in T cell receptor (TCR) signal strength into distinct developmental programs that drive the cell fate decisions towards conventional (Tconv) or regulatory T cells (Treg). Following TCR activation, intracellular calcium (Ca2+) is the most important second messenger, for which the potassium channel K2P18.1 is a relevant regulator. Here, we identify K2P18.1 as a central translator of the TCR signal into the thymus-derived Treg (tTreg) selection process. TCR signal was coupled to NF-κB-mediated K2P18.1 upregulation in tTreg progenitors. K2P18.1 provided the driving force for sustained Ca2+ influx that facilitated NF-κB- and NFAT-dependent expression of FoxP3, the master transcription factor for Treg development and function. Loss of K2P18.1 ion-current function induced a mild lymphoproliferative phenotype in mice, with reduced Treg numbers that led to aggravated experimental autoimmune encephalomyelitis, while a gain-of-function mutation in K2P18.1 resulted in increased Treg numbers in mice. Our findings in human thymus, recent thymic emigrants and multiple sclerosis patients with a dominant-negative missense K2P18.1 variant that is associated with poor clinical outcomes indicate that K2P18.1 also plays a role in human Treg development. Pharmacological modulation of K2P18.1 specifically modulated Treg numbers in vitro and in vivo. Finally, we identified nitroxoline as a K2P18.1 activator that led to rapid and reversible Treg increase in patients with urinary tract infections. Conclusively, our findings reveal how K2P18.1 translates TCR signals into thymic T cell fate decisions and Treg development, and provide a basis for the therapeutic utilization of Treg in several human disorders | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Forkhead Transcription Factors |2 NLM | |
| 650 | 7 | |a NF-kappa B |2 NLM | |
| 650 | 7 | |a Potassium Channels |2 NLM | |
| 650 | 7 | |a Receptors, Antigen, T-Cell |2 NLM | |
| 700 | 1 | |a Bock, Stefanie |e verfasserin |4 aut | |
| 700 | 1 | |a Pfeuffer, Steffen |e verfasserin |4 aut | |
| 700 | 1 | |a Schroeter, Christina B |e verfasserin |4 aut | |
| 700 | 1 | |a Cengiz, Derya |e verfasserin |4 aut | |
| 700 | 1 | |a Marciniak, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Lindner, Maren |e verfasserin |4 aut | |
| 700 | 1 | |a Herrmann, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Liebmann, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Kovac, Stjepana |e verfasserin |4 aut | |
| 700 | 1 | |a Gola, Lukas |e verfasserin |4 aut | |
| 700 | 1 | |a Rolfes, Leoni |e verfasserin |4 aut | |
| 700 | 1 | |a Pawlitzki, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Opel, Nils |e verfasserin |4 aut | |
| 700 | 1 | |a Hahn, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Dannlowski, Udo |e verfasserin |4 aut | |
| 700 | 1 | |a Pap, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Luessi, Felix |e verfasserin |4 aut | |
| 700 | 1 | |a Schreiber, Julian A |e verfasserin |4 aut | |
| 700 | 1 | |a Wünsch, Bernhard |e verfasserin |4 aut | |
| 700 | 1 | |a Kuhlmann, Tanja |e verfasserin |4 aut | |
| 700 | 1 | |a Seebohm, Guiscard |e verfasserin |4 aut | |
| 700 | 1 | |a Tackenberg, Björn |e verfasserin |4 aut | |
| 700 | 1 | |a Seja, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Döring, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Wischmeyer, Erhard |e verfasserin |4 aut | |
| 700 | 1 | |a Chasan, Achmet Imam |e verfasserin |4 aut | |
| 700 | 1 | |a Roth, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Klotz, Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Meyer Zu Hörste, Gerd |e verfasserin |4 aut | |
| 700 | 1 | |a Wiendl, Heinz |e verfasserin |4 aut | |
| 700 | 1 | |a Marschall, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Floess, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Huehn, Jochen |e verfasserin |4 aut | |
| 700 | 1 | |a Budde, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Bopp, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Bittner, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Meuth, Sven G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell research |d 1997 |g 32(2022), 1 vom: 26. Jan., Seite 72-88 |w (DE-627)NLM09215381X |x 1748-7838 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2022 |g number:1 |g day:26 |g month:01 |g pages:72-88 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41422-021-00580-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2022 |e 1 |b 26 |c 01 |h 72-88 | ||